National Pharmaceutical Regulatory Division (NPRA) has implemented Cold Chain Inspection (CCI) to be carried out on each lot of registered vaccine or plasma product that is imported to Malaysia since the Lot Release Activity implementation on January 2015 and July 2017 respectively. Effective 2nd October 2017, NPRA has a new work process as improvement of the existing cold chain inspection process.
| No | Document | Download |
| 1 | Guideline to Completing Vaccine Arrival Report (VAR) / Plasma Product Arrival Report (PPAR) | DOWNLOAD |
| 2 | Vaccine / Plasma Product Arrival Report | DOWNLOAD |
